Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGER: Angong Niuhuang Pill in Disabling Acute Ischemic Stroke
NCT07882030Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Oct 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Angong Niuhuang Pill with Matching Placebo (2 arms). Primary endpoint: Functional Independence (mRS 0-2) at 90 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07882030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882030.